Finding Solutions to the Latest Challenges
in Rx Drug Pricing

With both federal and state law makers engaging in greater scrutiny of prescription drug pricing, now is the time when industry professionals must stay up to date on the latest amendments to government payor programs as well as their impact on the private sector.

ACI’s Rx Drug Pricing Forum will provide you with the guidance you need to formulate solutions to conquer the latest challenges drug manufacturers are facing in the public payor arena.

 

Industry Keynote Address: Industry Perspectives on the Public Payor Landscape

James Stansel

Executive Vice President and General Counsel
PhRMA

BIO’s Thoughts on the Policies of Public Payors

John A Murphy

John A. Murphy

Deputy General Counsel
Biotechnology Innovation Organization (Washington, D.C.)

Enforcers Roundtable on Rx Drug Pricing

Viveca Parker

Assistant U.S. Attorney
The United States Attorney’s Office for the Eastern District of Pennsylvania

Steve Sharobem

Assistant U.S. Attorney
The United States Attorney’s Office for the District of Massachusetts

NEW for 2019

  • The latest amendments to Medicare parts B and D under the CMS Proposed Final Rule
  • The future of the PHS’s 340B program in the aftermath of American Hospital Association v. Azar
  • The perplexities of co-pay coupons, maximizers and accelerators
  • The expansion of federal and state transparency measures in relation to pricing
  • The role of online pharmacies in the drug pricing debate
  • The impact of pharmaceutical industry verticalization on prescription drug pricing under the Medicare and Medicaid programs

Don’t miss out on the pre-conference workshops to receive a full understanding of necessary pharmaceutical pricing concepts:

Workshop A

Government Payor Programs 101: Primer on the Pricing Essentials of the Medicare, Medicaid, and Big Four Programs

LEARN MORE

Workshop B

Medicare and Medicaid Pricing 2.0: Developing Practical Strategies for
Complex Pricing Challenges

LEARN MORE


Don’t miss this opportunity to benchmark your drug pricing strategies with top industry representatives. Register early to secure your place!

What Past Attendees Say:

“Excellent and fully capable list of speakers”
-VP US Commercial Legal, Lundbeck LLC

“All encompassing overview of government programs and current issues”
-Director, Pricing and Contracts, Horizon Pharmaceuticals


Who You Will Meet:

Pharmaceutical Companies

  • Corporate Counsel/General Counsel
  • Vice Presidents, Officers, Directors and Managers for:
    • — Pricing, Pricing Strategy,
      Pricing Analytics
    • — Contracts and
      Reimbursement
    • — Managed Care
    • — Government Programs
    • — Medicaid/Medicare
      Rebates
    • — Finance/Accounting/Audit
    • — Government Affairs
    • — Marketing
  • Compliance Officers

Law Firms

  • Attorneys with practice areas in:
    • — Pharmaceuticals
    • — Healthcare
    • — Food & Drug
PBMs

  • Corporate Counsel/General Counsel
  • Vice Presidents, Officers, Directors and Managers for:
    • — Contract Management
    • — Network Pharmacy
    • — Retail Pharmacy Operations
    • — Government Programs
    • — Pricing and Operations
    • — Clinical Operations
    • — Industry Relations/Government Affairs
  • Financial Analysts

Pharmacies

  • Corporate Counsel/General Counsel
  • Vice Presidents, Officers, Directors and Managers for:
  • Pricing
  • Business Development

Plans

  • Corporate Counsel/General Counsel
  • Vice Presidents, Officers, Directors and Managers for:
    • — Pharmacy Networks
    • — Pharmaceutical Contracting
    • — Clinical
    • — Pharmacy Services


Event Contacts

Sponsorship Opportunities:

American Conference Institute
Email Us

Media Partnership Opportunities:

Andrea Sachs
Tel: 212-352-3220 ext. 5224
Email Us

Programme Information and Speaking:

Marc Gerstein
Tel: 212.352.3220 ext. 5530
Email Us